A direct-to-patient access workflow and a clinic's procurement relationship are different operating arrangements.
Affected arrangements: Clinics considering facilitated branded access alongside an existing dispensing partner.
Understand the reference workflow
LillyDirect describes a direct-to-patient experience using licensed third-party dispensing pharmacies. The FAQ explains that the dispensing pharmacy contacts the patient after a valid prescription is received, with subsequent information checks and checkout. This is useful workflow evidence, not confirmation that a clinic has wholesale purchasing rights, negotiated allocation or a particular programme entitlement.
Compare like responsibilities
Build parallel rows for eligibility enquiries, prescription routing, payer checks, patient payment, dispensing, delivery, refill communication and escalation. For each row, state whether the clinic, access programme, pharmacy or patient acts. A blank responsibility field represents an operational question, even where the medicine itself is clearly identified.
Attach commercial conditions
Record the exact medicine format, current programme terms, applicable patient assumptions, introductory period and ongoing period. Keep patient expenditure separate from clinic support costs. Do not take a headline self-pay amount and treat it as the clinic's acquisition price. Date the captured terms and ask who will recheck them before launch.
Test the exception journey
Use a non-patient example: a prescription is incomplete, payment is delayed or the expected format is unavailable. Identify the queue owner, escalation channel and visibility the clinic will receive. The comparison is useful when it reveals work the clinic must still perform. A reference link does not establish a partnership or endorsement by LillyDirect.
Questions to take forward
- Who owns each exception after the prescription is sent?
- Which costs are patient-paid and which are clinic-paid?
- What reporting can the clinic actually receive?
Primary sources & evidence limits
LillyDirect: Patient FAQs and workflow ↗Publication date not stated · Accessed 2026-11-17Primary-source links were opened or retrieved on 17 November 2026. This date records source access, not legal or clinical review. Procurement checklists and commercial models are editorial methods. No live supplier, licence, coverage or capacity verification has been performed.